Image

Promote Awareness of the Driving Abilities of Post-stroke Patients.

Promote Awareness of the Driving Abilities of Post-stroke Patients.

Recruiting
18-85 years
All
Phase N/A

Powered by AI

Overview

Patients with cerebrovascular accident (CVA) may present with a deficit of awareness of the disorders which results in a lack of correct self-estimation of their own abilities and difficulties in terms of both cognition and driving. It is therefore important to develop tools to help professionals take this deficit into account in their driving assessments and also to help patients better identify their real abilities.

This research project thus proposes a protocol making it possible to promote decision-making whether or not to resume driving by multidisciplinary teams.

The main objective is to determine to what extent video feedback promotes awareness of the ability to manage post-stroke patients, compared to a group of control patients receiving the usual recommendations.

Eligibility

Inclusion Criteria:

  • Stroke (ischemic and / or hemorrhagic) between 1 month and 6 months
  • Holder of a driving license for more than 3 years
  • No resumption of driving
  • MoCA score ≥ 10
  • Affiliation to a social security scheme or beneficiary of such a scheme
  • Having signed a free, informed and written consent
  • Medically stable

Exclusion Criteria:

  • Aphasia with severe comprehension disturbances, severe hemineglect, unstable epilepsy, severe visual disturbances (binocular vision <6/10, visual field <120 ° in binocular, <50 ° to the right and to the left beyond the central point, <30 ° vertically.
  • History of neurological disease responsible for cognitive impairment
  • Need for vehicle modifications except automatic gearbox
  • Subject being in a period of exclusion from another protocol
  • Insufficient command of the French language
  • Protected adults (curators)
  • Pregnancy declared
  • Being unable to issue their consent

Study details
    Cerebrovascular Accident

NCT06530134

Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.